Skip to content
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne
Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports Other Valves & Manifolds Rheodyne

Rheodyne Two Position Three-Way Valve With Six 1/6 in. Ports

by Rheodyne
Availability:
Only 1 left!
SKU 9769
Save 29% Save 29%
$335.00
$335.00 - $335.00
$335.00
$237.50
$237.50 - $237.50
$237.50

The Rheodyne 7030 Two Position Three-Way Valve is a manual valve used in liquid chromatography and other fluidic systems to switch the flow path of a mobile phase. This particular model has six 1/16-inch ports and can be manually actuated to connect the ports in two distinct configurations. This valve has a simple, on-off, two-position design. However, the three-way nature means it can switch the flow between two different inputs or outputs. It is often used to divert flow, select between two mobile phases, or trap a specific fraction.

Used, in good condition.

Please note that Life Sciences Trading is not a factory-authorized distributor of the products listed in this store. The items have been acquired as surplus from leading life sciences companies.